Publikationen, an denen er mitarbeitet Nicolás Merchante Gutiérrez (9)

2023

  1. Role of IP-10 to Predict Clinical Progression and Response to IL-6 Blockade With Sarilumab in Early COVID-19 Pneumonia. A Subanalysis of the SARICOR Clinical Trial

    Open Forum Infectious Diseases, Vol. 10, Núm. 4

2022

  1. Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: The SARICOR Randomized Clinical Trial

    Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 2

2020

  1. Efficacy and safety of early treatment with sarilumab in hospitalised adults with COVID-19 presenting cytokine release syndrome (SARICOR STUDY): Protocol of a phase II, open-label, randomised, multicentre, controlled clinical trial

    BMJ Open, Vol. 10, Núm. 11

2017

  1. Week 4 response predicts sustained virological response to all-oral direct-acting antiviral-based therapy in cirrhotic patients with hepatitis C virus genotype 3 infection

    Clinical Microbiology and Infection, Vol. 23, Núm. 6, pp. 409.e5-409.e8

2013

  1. Incidence of Liver Damage of Uncertain Origin in HIV Patients Not Co-Infected with HCV/HBV

    PLoS ONE, Vol. 8, Núm. 7

2011

  1. Twelve week post-treatment follow-up predicts sustained virological response to pegylated interferon and ribavirin therapy in HIV/hepatitis C virus co-infected patients

    Journal of Antimicrobial Chemotherapy, Vol. 66, Núm. 6, pp. 1351-1353

2010

  1. Changes in liver stiffness in patients with chronic hepatitis C with and without HIV co-infection treated with pegylated interferon plus ribavirin

    Journal of Antimicrobial Chemotherapy, Vol. 65, Núm. 10, pp. 2204-2211

  2. Prevalence and risk factors for abnormal liver stiffness in HIV-infected patients without viral hepatitis coinfection: Role of didanosine

    Antiviral Therapy, Vol. 15, Núm. 5, pp. 753-763

2009

  1. Insulin resistance is associated with liver stiffness in HIV/HCV co-infected patients

    Gut, Vol. 58, Núm. 12, pp. 1654-1660